SAGE Therapeutics Inc
SWB:SG7
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
S
|
SAGE Therapeutics Inc
SWB:SG7
|
US |
|
A
|
Apotea AB (publ)
F:V30
|
SE |
Shareholder Yield
Current shareholder yield for
SG7 is
.
Peers Comparison
Shareholder Yield
Price Appreciation
SG7 Price
SAGE Therapeutics Inc
| Average Annual Return | -29.12% |
| Standard Deviation of Annual Returns | 19.24% |
| Max Drawdown | -94% |
| Market Capitalization | 543.6m EUR |
| Shares Outstanding | 60 182 031 |
| Percentage of Shares Shorted |
N/A
|